Consistent with our clinical findings, a recent analysis of lipoprotein receptors in clinical prostate cancer showed that SRB1 mRNA correlated with HSD3B1 expression, and patients with high tumoral SRB1 levels had shorter progression‐free survival (Schorghofer et al, 2015). The gene discussed is HSD3B1; the disease is prostate carcinoma.